Regorafenib Plus 5-Fluorouracil/Leucovorin Beyond Progression in mCRC

NCT03099486 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped Administrative change

Conditions

Colorectal Cancer

Interventions

DRUG: Regorafenib
DRUG: 5-FU
DRUG: Leucovorin

Sponsor

Fox Chase Cancer Center